Sunday, September 20, 2026
RSS


← All Stories

Markets-and-Money
Macy's Q2 Performance: A Beacon for Retail Investors in a Tough Market

Macy's Q2 results exceed expectations, raising full-year guidance and signaling a promising turnaround amid broader mark…

Marcus Rivera • Sep 10, 2026
Markets-and-Money
John Marshall Bank's $253M Eagle Financial Grab: The Consolidation Playbook Reshapes Virginia Banking

John Marshall Bank's all-stock acquisition of Eagle Financial Services signals a broader reshuffling in regional banking…

Marcus Rivera • Sep 8, 2026
Markets-and-Money
Labcorp's Strategic Acquisition of MLM Medical Labs: What It Means for Investors

Labcorp's acquisition of MLM Medical Labs signals a shift in the diagnostics landscape with potential investor implicati…

Marcus Rivera • Sep 8, 2026
Markets-and-Money
PayPal Pumps the Brakes on VC Portfolio Sale — What the Pause Signals About PYPL's Strategy

PayPal halts venture capital portfolio sale amid tighter M&A conditions. Investors weigh whether the pause reflects mark…

Marcus Rivera • Sep 5, 2026
Markets-and-Money
Blowout August Jobs Report Sends 2-Year Treasury Yield to 16-Month High — Is a September Fed Hike Back on the Table?

Hot August payrolls data pushes 2-year Treasury yields to January 2025 highs, reigniting rate-hike expectations. Equity …

Sarah Chen • Sep 5, 2026
Markets-and-Money
Rising Treasury Yields and Job Growth: What It Means for Investors

Rising Treasury yields and robust job growth signal a potential shift in the investment landscape.

Marcus Rivera • Sep 4, 2026
Markets-and-Money
US Jobs Report Fuels Treasury Yield Surge and Market Uncertainty

The latest jobs report has sent Treasury yields soaring, raising questions about future Fed rate hikes and market stabil…

Sarah Chen • Sep 4, 2026
Markets-and-Money
Speculation Surrounding PayPal: What Investors Should Know About the Takeover Buzz

PayPal's stock rises amid takeover speculation, prompting discussions on its future as a standalone entity versus an acq…

Marcus Rivera • Sep 3, 2026
Markets-and-Money
AbbVie Expands Its Horizons with $11 Billion Acquisition of Apogee Therapeutics

AbbVie’s $11 billion acquisition of Apogee Therapeutics signals strategic growth in immunology and highlights M&A trends…

Sarah Chen • Sep 3, 2026
Markets-and-Money
AbbVie's $11 Billion Bet on Apogee Therapeutics: A New Era for Biotech?

AbbVie has acquired Apogee Therapeutics for $11 billion, signaling a pivotal shift in its strategy post-Humira.

Sarah Chen • Sep 3, 2026
Markets-and-Money
Definitive Healthcare Stock Rallies on Advent International Buyout News

Definitive Healthcare sees a significant stock surge following a buyout offer from Advent International, raising questio…

James McAllister • Sep 2, 2026
Markets-and-Money
September Stock Market Outlook: Rising Treasury Yields and Their Impact on Investments

As Treasury yields climb, investors face new challenges in the stock market this September.

Marcus Rivera • Sep 1, 2026